The global market for Ophthalmology Therapeutics was estimated to be worth US$ 143.2 million in 2023 and is forecast to a readjusted size of US$ 199.8 million by 2030 with a CAGR of 4.8% during the forecast period 2024-2030

Ophthalmology Therapeutics - Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Ophthalmology Therapeutics, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Ophthalmology Therapeutics by region & country, by Type, and by Application.

The Ophthalmology Therapeutics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ophthalmology Therapeutics.

Market Segmentation

Scope of Ophthalmology Therapeutics - Market Report

Report Metric	Details
Report Name	Ophthalmology Therapeutics - Market
Forecasted market size in 2030	US$ 199.8 million
CAGR	4.8%
Forecasted years	2024 - 2030
Segment by Type:	Gels Eye Solutions Capsules & Tablets Ointments
Segment by Application	Glaucoma Dry Eye Syndrome Eye Infection Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AbbVie, Aerie Pharmaceuticals, Bayer, F. Hoffmann-La Roche, Novartis AG, Otsuka Holdings, Pfizer, Regeneron Pharmaceuticals, Santen Pharmaceutical, Teva Pharmaceutical Industries
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Ophthalmology Therapeutics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Ophthalmology Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Ophthalmology Therapeutics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Ophthalmology Therapeutics - Market size in 2030?

Ans: The Ophthalmology Therapeutics - Market size in 2030 will be US$ 199.8 million.

Who are the main players in the Ophthalmology Therapeutics - Market report?

Ans: The main players in the Ophthalmology Therapeutics - Market are AbbVie, Aerie Pharmaceuticals, Bayer, F. Hoffmann-La Roche, Novartis AG, Otsuka Holdings, Pfizer, Regeneron Pharmaceuticals, Santen Pharmaceutical, Teva Pharmaceutical Industries

What are the Application segmentation covered in the Ophthalmology Therapeutics - Market report?

Ans: The Applications covered in the Ophthalmology Therapeutics - Market report are Glaucoma, Dry Eye Syndrome, Eye Infection, Other

What are the Type segmentation covered in the Ophthalmology Therapeutics - Market report?

Ans: The Types covered in the Ophthalmology Therapeutics - Market report are Gels, Eye Solutions, Capsules & Tablets, Ointments

1 Market Overview

1.1 Ophthalmology Therapeutics Product Introduction

1.2 Global Ophthalmology Therapeutics Market Size Forecast

1.2.1 Global Ophthalmology Therapeutics Sales Value (2019-2030)

1.2.2 Global Ophthalmology Therapeutics Sales Volume (2019-2030)

1.2.3 Global Ophthalmology Therapeutics Sales Price (2019-2030)

1.3 Ophthalmology Therapeutics Market Trends & Drivers

1.3.1 Ophthalmology Therapeutics Industry Trends

1.3.2 Ophthalmology Therapeutics Market Drivers & Opportunity

1.3.3 Ophthalmology Therapeutics Market Challenges

1.3.4 Ophthalmology Therapeutics Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Ophthalmology Therapeutics Players Revenue Ranking (2023)

2.2 Global Ophthalmology Therapeutics Revenue by Company (2019-2024)

2.3 Global Ophthalmology Therapeutics Players Sales Volume Ranking (2023)

2.4 Global Ophthalmology Therapeutics Sales Volume by Company Players (2019-2024)

2.5 Global Ophthalmology Therapeutics Average Price by Company (2019-2024)

2.6 Key Manufacturers Ophthalmology Therapeutics Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Ophthalmology Therapeutics Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Ophthalmology Therapeutics

2.9 Ophthalmology Therapeutics Market Competitive Analysis

2.9.1 Ophthalmology Therapeutics Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Ophthalmology Therapeutics Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophthalmology Therapeutics as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Gels

3.1.2 Eye Solutions

3.1.3 Capsules & Tablets

3.1.4 Ointments

3.2 Global Ophthalmology Therapeutics Sales Value by Type

3.2.1 Global Ophthalmology Therapeutics Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Ophthalmology Therapeutics Sales Value, by Type (2019-2030)

3.2.3 Global Ophthalmology Therapeutics Sales Value, by Type (%) (2019-2030)

3.3 Global Ophthalmology Therapeutics Sales Volume by Type

3.3.1 Global Ophthalmology Therapeutics Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Ophthalmology Therapeutics Sales Volume, by Type (2019-2030)

3.3.3 Global Ophthalmology Therapeutics Sales Volume, by Type (%) (2019-2030)

3.4 Global Ophthalmology Therapeutics Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Glaucoma

4.1.2 Dry Eye Syndrome

4.1.3 Eye Infection

4.1.4 Other

4.2 Global Ophthalmology Therapeutics Sales Value by Application

4.2.1 Global Ophthalmology Therapeutics Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Ophthalmology Therapeutics Sales Value, by Application (2019-2030)

4.2.3 Global Ophthalmology Therapeutics Sales Value, by Application (%) (2019-2030)

4.3 Global Ophthalmology Therapeutics Sales Volume by Application

4.3.1 Global Ophthalmology Therapeutics Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Ophthalmology Therapeutics Sales Volume, by Application (2019-2030)

4.3.3 Global Ophthalmology Therapeutics Sales Volume, by Application (%) (2019-2030)

4.4 Global Ophthalmology Therapeutics Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Ophthalmology Therapeutics Sales Value by Region

5.1.1 Global Ophthalmology Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Ophthalmology Therapeutics Sales Value by Region (2019-2024)

5.1.3 Global Ophthalmology Therapeutics Sales Value by Region (2025-2030)

5.1.4 Global Ophthalmology Therapeutics Sales Value by Region (%), (2019-2030)

5.2 Global Ophthalmology Therapeutics Sales Volume by Region

5.2.1 Global Ophthalmology Therapeutics Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Ophthalmology Therapeutics Sales Volume by Region (2019-2024)

5.2.3 Global Ophthalmology Therapeutics Sales Volume by Region (2025-2030)

5.2.4 Global Ophthalmology Therapeutics Sales Volume by Region (%), (2019-2030)

5.3 Global Ophthalmology Therapeutics Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Ophthalmology Therapeutics Sales Value, 2019-2030

5.4.2 North America Ophthalmology Therapeutics Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Ophthalmology Therapeutics Sales Value, 2019-2030

5.5.2 Europe Ophthalmology Therapeutics Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Ophthalmology Therapeutics Sales Value, 2019-2030

5.6.2 Asia Pacific Ophthalmology Therapeutics Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Ophthalmology Therapeutics Sales Value, 2019-2030

5.7.2 South America Ophthalmology Therapeutics Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Ophthalmology Therapeutics Sales Value, 2019-2030

5.8.2 Middle East & Africa Ophthalmology Therapeutics Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Ophthalmology Therapeutics Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Ophthalmology Therapeutics Sales Value

6.2.1 Key Countries/Regions Ophthalmology Therapeutics Sales Value, 2019-2030

6.2.2 Key Countries/Regions Ophthalmology Therapeutics Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Ophthalmology Therapeutics Sales Value, 2019-2030

6.3.2 United States Ophthalmology Therapeutics Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Ophthalmology Therapeutics Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Ophthalmology Therapeutics Sales Value, 2019-2030

6.4.2 Europe Ophthalmology Therapeutics Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Ophthalmology Therapeutics Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Ophthalmology Therapeutics Sales Value, 2019-2030

6.5.2 China Ophthalmology Therapeutics Sales Value by Type (%), 2023 VS 2030

6.5.3 China Ophthalmology Therapeutics Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Ophthalmology Therapeutics Sales Value, 2019-2030

6.6.2 Japan Ophthalmology Therapeutics Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Ophthalmology Therapeutics Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Ophthalmology Therapeutics Sales Value, 2019-2030

6.7.2 South Korea Ophthalmology Therapeutics Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Ophthalmology Therapeutics Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Ophthalmology Therapeutics Sales Value, 2019-2030

6.8.2 Southeast Asia Ophthalmology Therapeutics Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Ophthalmology Therapeutics Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Ophthalmology Therapeutics Sales Value, 2019-2030

6.9.2 India Ophthalmology Therapeutics Sales Value by Type (%), 2023 VS 2030

6.9.3 India Ophthalmology Therapeutics Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 AbbVie

7.1.1 AbbVie Company Information

7.1.2 AbbVie Introduction and Business Overview

7.1.3 AbbVie Ophthalmology Therapeutics Sales, Revenue and Gross Margin (2019-2024)

7.1.4 AbbVie Ophthalmology Therapeutics Product Offerings

7.1.5 AbbVie Recent Development

7.2 Aerie Pharmaceuticals

7.2.1 Aerie Pharmaceuticals Company Information

7.2.2 Aerie Pharmaceuticals Introduction and Business Overview

7.2.3 Aerie Pharmaceuticals Ophthalmology Therapeutics Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Aerie Pharmaceuticals Ophthalmology Therapeutics Product Offerings

7.2.5 Aerie Pharmaceuticals Recent Development

7.3 Bayer

7.3.1 Bayer Company Information

7.3.2 Bayer Introduction and Business Overview

7.3.3 Bayer Ophthalmology Therapeutics Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Bayer Ophthalmology Therapeutics Product Offerings

7.3.5 Bayer Recent Development

7.4 F. Hoffmann-La Roche

7.4.1 F. Hoffmann-La Roche Company Information

7.4.2 F. Hoffmann-La Roche Introduction and Business Overview

7.4.3 F. Hoffmann-La Roche Ophthalmology Therapeutics Sales, Revenue and Gross Margin (2019-2024)

7.4.4 F. Hoffmann-La Roche Ophthalmology Therapeutics Product Offerings

7.4.5 F. Hoffmann-La Roche Recent Development

7.5 Novartis AG

7.5.1 Novartis AG Company Information

7.5.2 Novartis AG Introduction and Business Overview

7.5.3 Novartis AG Ophthalmology Therapeutics Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Novartis AG Ophthalmology Therapeutics Product Offerings

7.5.5 Novartis AG Recent Development

7.6 Otsuka Holdings

7.6.1 Otsuka Holdings Company Information

7.6.2 Otsuka Holdings Introduction and Business Overview

7.6.3 Otsuka Holdings Ophthalmology Therapeutics Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Otsuka Holdings Ophthalmology Therapeutics Product Offerings

7.6.5 Otsuka Holdings Recent Development

7.7 Pfizer

7.7.1 Pfizer Company Information

7.7.2 Pfizer Introduction and Business Overview

7.7.3 Pfizer Ophthalmology Therapeutics Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Pfizer Ophthalmology Therapeutics Product Offerings

7.7.5 Pfizer Recent Development

7.8 Regeneron Pharmaceuticals

7.8.1 Regeneron Pharmaceuticals Company Information

7.8.2 Regeneron Pharmaceuticals Introduction and Business Overview

7.8.3 Regeneron Pharmaceuticals Ophthalmology Therapeutics Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Regeneron Pharmaceuticals Ophthalmology Therapeutics Product Offerings

7.8.5 Regeneron Pharmaceuticals Recent Development

7.9 Santen Pharmaceutical

7.9.1 Santen Pharmaceutical Company Information

7.9.2 Santen Pharmaceutical Introduction and Business Overview

7.9.3 Santen Pharmaceutical Ophthalmology Therapeutics Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Santen Pharmaceutical Ophthalmology Therapeutics Product Offerings

7.9.5 Santen Pharmaceutical Recent Development

7.10 Teva Pharmaceutical Industries

7.10.1 Teva Pharmaceutical Industries Company Information

7.10.2 Teva Pharmaceutical Industries Introduction and Business Overview

7.10.3 Teva Pharmaceutical Industries Ophthalmology Therapeutics Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Teva Pharmaceutical Industries Ophthalmology Therapeutics Product Offerings

7.10.5 Teva Pharmaceutical Industries Recent Development

8 Industry Chain Analysis

8.1 Ophthalmology Therapeutics Industrial Chain

8.2 Ophthalmology Therapeutics Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Ophthalmology Therapeutics Sales Model

8.5.2 Sales Channel

8.5.3 Ophthalmology Therapeutics Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

AbbVie

Aerie Pharmaceuticals

Santen Pharmaceutical

Teva Pharmaceutical Industries

Regeneron Pharmaceuticals

Pfizer Inc

List of Tables

Table 1. Ophthalmology Therapeutics Market Trends

Table 2. Ophthalmology Therapeutics Market Drivers & Opportunity

Table 3. Ophthalmology Therapeutics Market Challenges

Table 4. Ophthalmology Therapeutics Market Restraints

Table 5. Global Ophthalmology Therapeutics Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Ophthalmology Therapeutics Revenue Market Share by Company (2019-2024)

Table 7. Global Ophthalmology Therapeutics Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Ophthalmology Therapeutics Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Ophthalmology Therapeutics Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Ophthalmology Therapeutics Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Ophthalmology Therapeutics Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Ophthalmology Therapeutics

Table 13. Global Ophthalmology Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophthalmology Therapeutics as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Ophthalmology Therapeutics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Ophthalmology Therapeutics Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Ophthalmology Therapeutics Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Ophthalmology Therapeutics Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Ophthalmology Therapeutics Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Ophthalmology Therapeutics Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Ophthalmology Therapeutics Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Ophthalmology Therapeutics Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Ophthalmology Therapeutics Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Ophthalmology Therapeutics Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Ophthalmology Therapeutics Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Ophthalmology Therapeutics Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Ophthalmology Therapeutics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Ophthalmology Therapeutics Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Ophthalmology Therapeutics Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Ophthalmology Therapeutics Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Ophthalmology Therapeutics Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Ophthalmology Therapeutics Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Ophthalmology Therapeutics Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Ophthalmology Therapeutics Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Ophthalmology Therapeutics Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Ophthalmology Therapeutics Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Ophthalmology Therapeutics Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Ophthalmology Therapeutics Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Ophthalmology Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Ophthalmology Therapeutics Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Ophthalmology Therapeutics Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Ophthalmology Therapeutics Sales Value by Region (2019-2024) & (%)

Table 44. Global Ophthalmology Therapeutics Sales Value by Region (2025-2030) & (%)

Table 45. Global Ophthalmology Therapeutics Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Ophthalmology Therapeutics Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Ophthalmology Therapeutics Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Ophthalmology Therapeutics Sales Volume by Region (2019-2024) & (%)

Table 49. Global Ophthalmology Therapeutics Sales Volume by Region (2025-2030) & (%)

Table 50. Global Ophthalmology Therapeutics Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Ophthalmology Therapeutics Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Ophthalmology Therapeutics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Ophthalmology Therapeutics Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Ophthalmology Therapeutics Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Ophthalmology Therapeutics Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Ophthalmology Therapeutics Sales Volume, (2025-2030) & (K Units)

Table 57. AbbVie Company Information

Table 58. AbbVie Introduction and Business Overview

Table 59. AbbVie Ophthalmology Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. AbbVie Ophthalmology Therapeutics Product Offerings

Table 61. AbbVie Recent Development

Table 62. Aerie Pharmaceuticals Company Information

Table 63. Aerie Pharmaceuticals Introduction and Business Overview

Table 64. Aerie Pharmaceuticals Ophthalmology Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Aerie Pharmaceuticals Ophthalmology Therapeutics Product Offerings

Table 66. Aerie Pharmaceuticals Recent Development

Table 67. Bayer Company Information

Table 68. Bayer Introduction and Business Overview

Table 69. Bayer Ophthalmology Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. Bayer Ophthalmology Therapeutics Product Offerings

Table 71. Bayer Recent Development

Table 72. F. Hoffmann-La Roche Company Information

Table 73. F. Hoffmann-La Roche Introduction and Business Overview

Table 74. F. Hoffmann-La Roche Ophthalmology Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. F. Hoffmann-La Roche Ophthalmology Therapeutics Product Offerings

Table 76. F. Hoffmann-La Roche Recent Development

Table 77. Novartis AG Company Information

Table 78. Novartis AG Introduction and Business Overview

Table 79. Novartis AG Ophthalmology Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Novartis AG Ophthalmology Therapeutics Product Offerings

Table 81. Novartis AG Recent Development

Table 82. Otsuka Holdings Company Information

Table 83. Otsuka Holdings Introduction and Business Overview

Table 84. Otsuka Holdings Ophthalmology Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Otsuka Holdings Ophthalmology Therapeutics Product Offerings

Table 86. Otsuka Holdings Recent Development

Table 87. Pfizer Company Information

Table 88. Pfizer Introduction and Business Overview

Table 89. Pfizer Ophthalmology Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. Pfizer Ophthalmology Therapeutics Product Offerings

Table 91. Pfizer Recent Development

Table 92. Regeneron Pharmaceuticals Company Information

Table 93. Regeneron Pharmaceuticals Introduction and Business Overview

Table 94. Regeneron Pharmaceuticals Ophthalmology Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. Regeneron Pharmaceuticals Ophthalmology Therapeutics Product Offerings

Table 96. Regeneron Pharmaceuticals Recent Development

Table 97. Santen Pharmaceutical Company Information

Table 98. Santen Pharmaceutical Introduction and Business Overview

Table 99. Santen Pharmaceutical Ophthalmology Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 100. Santen Pharmaceutical Ophthalmology Therapeutics Product Offerings

Table 101. Santen Pharmaceutical Recent Development

Table 102. Teva Pharmaceutical Industries Company Information

Table 103. Teva Pharmaceutical Industries Introduction and Business Overview

Table 104. Teva Pharmaceutical Industries Ophthalmology Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 105. Teva Pharmaceutical Industries Ophthalmology Therapeutics Product Offerings

Table 106. Teva Pharmaceutical Industries Recent Development

Table 107. Key Raw Materials Lists

Table 108. Raw Materials Key Suppliers Lists

Table 109. Ophthalmology Therapeutics Downstream Customers

Table 110. Ophthalmology Therapeutics Distributors List

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

List of Figures

Figure 1. Ophthalmology Therapeutics Product Picture

Figure 2. Global Ophthalmology Therapeutics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Ophthalmology Therapeutics Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Ophthalmology Therapeutics Sales Volume (2019-2030) & (K Units)

Figure 5. Global Ophthalmology Therapeutics Sales Price (2019-2030) & (US$/Unit)

Figure 6. Ophthalmology Therapeutics Report Years Considered

Figure 7. Global Ophthalmology Therapeutics Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Ophthalmology Therapeutics Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Ophthalmology Therapeutics Revenue in 2023

Figure 10. Ophthalmology Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Gels Picture

Figure 12. Eye Solutions Picture

Figure 13. Capsules & Tablets Picture

Figure 14. Ointments Picture

Figure 15. Global Ophthalmology Therapeutics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 16. Global Ophthalmology Therapeutics Sales Value Market Share by Type, 2023 & 2030

Figure 17. Global Ophthalmology Therapeutics Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 18. Global Ophthalmology Therapeutics Sales Volume Market Share by Type, 2023 & 2030

Figure 19. Global Ophthalmology Therapeutics Price by Type (2019-2030) & (US$/Unit)

Figure 20. Product Picture of Glaucoma

Figure 21. Product Picture of Dry Eye Syndrome

Figure 22. Product Picture of Eye Infection

Figure 23. Product Picture of Other

Figure 24. Global Ophthalmology Therapeutics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 25. Global Ophthalmology Therapeutics Sales Value Market Share by Application, 2023 & 2030

Figure 26. Global Ophthalmology Therapeutics Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 27. Global Ophthalmology Therapeutics Sales Volume Market Share by Application, 2023 & 2030

Figure 28. Global Ophthalmology Therapeutics Price by Application (2019-2030) & (US$/Unit)

Figure 29. North America Ophthalmology Therapeutics Sales Value (2019-2030) & (US$ Million)

Figure 30. North America Ophthalmology Therapeutics Sales Value by Country (%), 2023 VS 2030

Figure 31. Europe Ophthalmology Therapeutics Sales Value (2019-2030) & (US$ Million)

Figure 32. Europe Ophthalmology Therapeutics Sales Value by Country (%), 2023 VS 2030

Figure 33. Asia Pacific Ophthalmology Therapeutics Sales Value (2019-2030) & (US$ Million)

Figure 34. Asia Pacific Ophthalmology Therapeutics Sales Value by Country (%), 2023 VS 2030

Figure 35. South America Ophthalmology Therapeutics Sales Value (2019-2030) & (US$ Million)

Figure 36. South America Ophthalmology Therapeutics Sales Value by Country (%), 2023 VS 2030

Figure 37. Middle East & Africa Ophthalmology Therapeutics Sales Value (2019-2030) & (US$ Million)

Figure 38. Middle East & Africa Ophthalmology Therapeutics Sales Value by Country (%), 2023 VS 2030

Figure 39. Key Countries/Regions Ophthalmology Therapeutics Sales Value (%), (2019-2030)

Figure 40. Key Countries/Regions Ophthalmology Therapeutics Sales Volume (%), (2019-2030)

Figure 41. United States Ophthalmology Therapeutics Sales Value, (2019-2030) & (US$ Million)

Figure 42. United States Ophthalmology Therapeutics Sales Value by Type (%), 2023 VS 2030

Figure 43. United States Ophthalmology Therapeutics Sales Value by Application (%), 2023 VS 2030

Figure 44. Europe Ophthalmology Therapeutics Sales Value, (2019-2030) & (US$ Million)

Figure 45. Europe Ophthalmology Therapeutics Sales Value by Type (%), 2023 VS 2030

Figure 46. Europe Ophthalmology Therapeutics Sales Value by Application (%), 2023 VS 2030

Figure 47. China Ophthalmology Therapeutics Sales Value, (2019-2030) & (US$ Million)

Figure 48. China Ophthalmology Therapeutics Sales Value by Type (%), 2023 VS 2030

Figure 49. China Ophthalmology Therapeutics Sales Value by Application (%), 2023 VS 2030

Figure 50. Japan Ophthalmology Therapeutics Sales Value, (2019-2030) & (US$ Million)

Figure 51. Japan Ophthalmology Therapeutics Sales Value by Type (%), 2023 VS 2030

Figure 52. Japan Ophthalmology Therapeutics Sales Value by Application (%), 2023 VS 2030

Figure 53. South Korea Ophthalmology Therapeutics Sales Value, (2019-2030) & (US$ Million)

Figure 54. South Korea Ophthalmology Therapeutics Sales Value by Type (%), 2023 VS 2030

Figure 55. South Korea Ophthalmology Therapeutics Sales Value by Application (%), 2023 VS 2030

Figure 56. Southeast Asia Ophthalmology Therapeutics Sales Value, (2019-2030) & (US$ Million)

Figure 57. Southeast Asia Ophthalmology Therapeutics Sales Value by Type (%), 2023 VS 2030

Figure 58. Southeast Asia Ophthalmology Therapeutics Sales Value by Application (%), 2023 VS 2030

Figure 59. India Ophthalmology Therapeutics Sales Value, (2019-2030) & (US$ Million)

Figure 60. India Ophthalmology Therapeutics Sales Value by Type (%), 2023 VS 2030

Figure 61. India Ophthalmology Therapeutics Sales Value by Application (%), 2023 VS 2030

Figure 62. Ophthalmology Therapeutics Industrial Chain

Figure 63. Ophthalmology Therapeutics Manufacturing Cost Structure

Figure 64. Channels of Distribution (Direct Sales, and Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Ophthalmic Pharmaceutical Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ophthalmic Drug Delivery Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ophthalmic Disease Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Ophthalmology AI assisted Diagnosis Software Market Research Report 2024

Global Ophthalmic Anti Infective Drugs Market Research Report 2025

Global Ocular Drug Delivery Market Research Report 2025

Global Pharma Ophthalmic Market Research Report 2025

Global Eye Drug Market Insights Forecast to 2030

Common Drugs Use in Ophthalmology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Choroid Therapy Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Computer Vision in Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prescription Dermatology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Retinal Disorder Treatment Market Research Report 2024

Diabetic Retinopathy Fundus Image assisted Diagnosis Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prescription Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Still s Disease Treatment Market Research Report 2025

Scar Removal Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Viral Conjunctivitis Pipeline Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Rheumatology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

[email protected]

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

	
		OSZAR »